P31749 (AKT1_HUMAN) Homo sapiens (Human)
RAC-alpha serine/threonine-protein kinase UniProtKBInterProSTRINGInteractive Modelling
480 aa; Sequence (Fasta) ; (Isoform 2);
6 identical sequences: Homo sapiens: B0LPE5; Pongo abelii: A0A2J8SZ71; Pan troglodytes: K7AGW5; Pan paniscus: A0A2R9BZ66; Gorilla gorilla gorilla: G3RB32; Nomascus leucogenys: G1S2V0
It is possible new templates exist for this target since these models were created.
Available Structures
36 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Structure of autoinhibited Akt1 reveals mechanism of PIP3-mediated activation |
Heteromer M4MD44; | |||||
| Assess | ||||||
| Crystal Structure of Akt-1 complexed with substrate peptide and inhibitor |
Heteromer P49841; | 1×MN; 1×CQW; | ||||
| Assess | ||||||
| Crystal Structure of Akt-1 complexed with substrate peptide and inhibitor |
Heteromer P49841; | 1×CQU; | ||||
| Assess | ||||||
| Spirochromane Akt Inhibitors |
Heteromer P49841; | 1×SMH; | ||||
| Assess | ||||||
| Crystal structure of AKT1 (aa 144-480) with a bisubstrate |
Heteromer P49841; | 1×SO4; 1×MN; | ||||
| Assess | ||||||
| Discovery of dihydrothieno- and dihydrofuropyrimidines as potent pan Akt inhibitors |
Heteromer P49841; | 1×SMY; | ||||
| Assess | ||||||
| Crystal structure of Akt-1-inhibitor complexes |
Heteromer P49841; | 1×MN; 1×XFE; | ||||
| Assess | ||||||
| Akt1 with AMP-PNP |
Heteromer P49841; | 1×ANP; 2×MN; | ||||
| Assess | ||||||
| Co-Crystal Structure of Akt1 in Complex with Covalent-Allosteric Akt Inhibitor 6 | monomer | 1×ACT; 1×UC8; | ||||
| Assess | ||||||
| Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 24b | monomer | 1×G4H; | ||||
| Assess | ||||||
| Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 16a | monomer | 1×L1Z; | ||||
| Assess | ||||||
| Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 27 | monomer | 1×G4T; | ||||
| Assess | ||||||
| Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 30b | monomer | 1×G4N; | ||||
| Assess | ||||||
| Co-Crystal Structure of Akt1 in Complex with Covalent-Allosteric Akt Inhibitor 3 | monomer | 1×UCE; 2×ACT; | ||||
| Assess | ||||||
| Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 15c | monomer | 1×L1W; | ||||
| Assess | ||||||
| Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 31 | monomer | 1×G4Q; | ||||
| Assess | ||||||
| Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor Borussertib | monomer | 1×G4K; | ||||
| Assess | ||||||
| Crystal structure of autoinhibited form of AKT1 in complex with N-(4-(5-(3-acetamidophenyl)-2-(2-am… | monomer | 1×0R4; 1×SBT; 1×EDO; | ||||
| Assess | ||||||
| Crystal structure of allosteric inhibitor, ARQ 092, in complex with autoinhibited form of AKT1 | monomer | 1×6S1; | ||||
| Assess | ||||||
| Crystal Structure of Human AKT1 with an Allosteric Inhibitor | monomer | 1×IQO; | ||||
| Assess | ||||||
| Crystal structure of Akt1 (aa 123-480) kinase with a bisubstrate | monomer | 2×MN; 2×PGE; | ||||
| Assess | ||||||
| Spirochromane Akt Inhibitors | monomer | 1×SMR; | ||||
| Assess | ||||||
| Akt1 with GDC0068 | monomer | 1×0RF; | ||||
| Assess | ||||||
| Spirocyclic sulfonamides as AKT inhibitors | monomer | 1×SM9; | ||||
| Assess | ||||||
| Akt1 kinase domain with pyrrolopyrimidine inhibitor | monomer | 1×XM1; | ||||
| Assess | ||||||
| PKB alpha in complex with AZD5363 | monomer | 1×0XZ; 4×GOL; | ||||
| Assess | ||||||
| Crystal structure of Akt-1-inhibitor complexes | monomer | 1×MN; 1×WFE; | ||||
| Assess | ||||||
| Crystal structure of Akt1 in complex with a selective inhibitor | monomer | 1×EX4; | ||||
| Assess | ||||||
| Crystal structure of the PH domain (R86A) of Akt1 | monomer | |||||
| Assess | ||||||
| Crystal structure of the pleckstrin homology domain of PKB alpha | monomer | |||||
| Assess | ||||||
| Crystal structure of the PH domain of PKB alpha in complex with a sulfate molecule | monomer | 1×SO4; | ||||
| Assess | ||||||
| A transforming mutation in the pleckstrin homology domain of AKT1 in cancer (AKT1-PH_E17K) | monomer | |||||
| Assess | ||||||
| High resolution crystal structure of the Pleckstrin Homology Domain Of Protein Kinase B/Akt Bound T… | monomer | 1×4IP; | ||||
| Assess | ||||||
| A transforming mutation in the pleckstrin homology domain of AKT1 in cancer (AKT1-PH_E17K) | monomer | 1×4IP; | ||||
| Assess | ||||||
| HIGH RESOLUTION STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN OF PROTEIN KINASE B/AKT BOUND TO INS(1,… | monomer | 1×4IP; | ||||
| Assess | ||||||
| Structure of PKBalpha PH domain in complex with a novel inositol headgroup surrogate, benzene 1,2,3… | monomer | 1×GVF; 1×NA; | ||||
| Assess | ||||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6hhj.1.A | monomer | 0.78 | 1×G4H; | 99.33 | ||
| Assess | ||||||
| 4y93.1.A | monomer | 0.59 | 20.26 | |||
| Assess | ||||||
2 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 6hhj.1.A | monomer | 0.77 | 99.22 | ||
| Assess | ||||||
| Isoform 2 | 7mt8.1.A | monomer | 0.65 | 35.71 | ||
| Assess | ||||||